These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 7678546

  • 1. Repression of neu-induced clonogenicity by dimethylsulfoxide correlates with decreased levels of neu-encoded cell-surface p185 and changes in phosphotyrosine content of endogenous proteins.
    Matin A, Hung MC.
    Cancer Lett; 1993 Jan 15; 68(1):55-60. PubMed ID: 7678546
    [Abstract] [Full Text] [Related]

  • 2. Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.
    Reardon DB, Hung MC.
    J Biol Chem; 1993 Aug 25; 268(24):18136-42. PubMed ID: 7688739
    [Abstract] [Full Text] [Related]

  • 3. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.
    Bargmann CI, Weinberg RA.
    Proc Natl Acad Sci U S A; 1988 Aug 25; 85(15):5394-8. PubMed ID: 2899890
    [Abstract] [Full Text] [Related]

  • 4. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
    Stern DF, Heffernan PA, Weinberg RA.
    Mol Cell Biol; 1986 May 25; 6(5):1729-40. PubMed ID: 2878363
    [Abstract] [Full Text] [Related]

  • 5. TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro.
    Cao H, Decker S, Stern DF.
    Oncogene; 1991 May 25; 6(5):705-11. PubMed ID: 1675782
    [Abstract] [Full Text] [Related]

  • 6. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.
    Stern DF, Kamps MP, Cao H.
    Mol Cell Biol; 1988 Sep 25; 8(9):3969-73. PubMed ID: 2464744
    [Abstract] [Full Text] [Related]

  • 7. Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene.
    Yarden Y, Weinberg RA.
    Proc Natl Acad Sci U S A; 1989 May 25; 86(9):3179-83. PubMed ID: 2470093
    [Abstract] [Full Text] [Related]

  • 8. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y, Dobashi K, Weiner DB, Myers JN, Nowell PC, Greene MI.
    Proc Natl Acad Sci U S A; 1988 Aug 25; 85(15):5389-93. PubMed ID: 2899889
    [Abstract] [Full Text] [Related]

  • 9. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.
    Yu D, Shi D, Scanlon M, Hung MC.
    Cancer Res; 1993 Dec 01; 53(23):5784-90. PubMed ID: 7902209
    [Abstract] [Full Text] [Related]

  • 10. Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.
    Drebin JA, Link VC, Stern DF, Weinberg RA, Greene MI.
    Cell; 1985 Jul 01; 41(3):697-706. PubMed ID: 2860972
    [Abstract] [Full Text] [Related]

  • 11. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L, Sistonen L, Koskinen P, Lehväslaiho H, Di Renzo MF, Comoglio PM, Alitalo K.
    J Cell Biochem; 1991 Jan 01; 45(1):69-81. PubMed ID: 1706346
    [Abstract] [Full Text] [Related]

  • 12. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP, Sefton BM.
    Oncogene Res; 1988 Sep 01; 3(2):105-15. PubMed ID: 2465525
    [Abstract] [Full Text] [Related]

  • 13. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
    Connelly PA, Stern DF.
    Proc Natl Acad Sci U S A; 1990 Aug 01; 87(16):6054-7. PubMed ID: 1974718
    [Abstract] [Full Text] [Related]

  • 14. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
    Muthuswamy SK, Muller WJ.
    Oncogene; 1995 Nov 02; 11(9):1801-10. PubMed ID: 7478608
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo.
    Drebin JA, Link VC, Greene MI.
    Oncogene; 1988 Apr 02; 2(4):387-94. PubMed ID: 2896329
    [Abstract] [Full Text] [Related]

  • 16. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin.
    Zhang L, Chang CJ, Bacus SS, Hung MC.
    Cancer Res; 1995 Sep 01; 55(17):3890-6. PubMed ID: 7543819
    [Abstract] [Full Text] [Related]

  • 17. Ligand-independent tyrosine phosphorylation of the receptor encoded by the c-neu oncogene.
    Boccaccio C, Gaudino G, Cilli M, Mondino A, Comoglio PM.
    Growth Factors; 1991 Sep 01; 5(3):233-42. PubMed ID: 1685656
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.